| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| AutoGenomics (AGMX) | Stifel/ Canaccord Genuity/ Cantor Fitzgerald | $60.00 | n.a. | |||
| Histogenics (HSGX) | Cowen and Company/ Needham & Company/ Canaccord Genuity | $65.00 | n.a. | |||
| INC Research Holdings (INCR) | Goldman Sachs/ Credit Suisse/ Baird/ Wells Fargo Securities/ William Blair | $150.00 | n.a. | |||
| Intercorp Financial Services (IFSP) | BofA Merrill Lynch/ Credit Suisse | $400.00 | n.a. | |||
| Landmark Infrastructure Partners LP (LMRK) | Baird/ Raymond James/ RBC Capital Markets | $50.00 | n.a. | |||
| Navios Maritime Midstream Partners LP (TBA) | BofA Merrill Lynch/ Citigroup/ Credit Suisse/ J.P. Morgan | $100.00 | n.a. | |||
| OneMain Financial Holdings (TBA) | Citigroup | $50.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| Postponed | ||||||
| NeuroSigma (NSIG) | Jefferies | 3.57 | $13.00 | $15.00 | $50.00 | 1-Star |
| Withdrawn | ||||||
| none | ||||||
| New Terms | ||||||
| Adama Agricultural Solutions Ltd. (TBA) | Goldman Sachs/ BofA Merrill Lynch | $400.00 | n.a. | |||
| Atara Biotherapeutics (ATRA) | Goldman Sachs/ Citigroup | 5.00 | $14.00 | $16.00 | $75.00 | 2-Stars |
| Dominion Midstream Partners, LP (DM) | Barclays/ Citigroup/ J.P. Morgan | 17.50 | $19.00 | $21.00 | $350.00 | 2-Stars |
| Fifth Street Asset Management (FSAM) | Morgan Stanley/ J.P. Morgan/ Goldman Sachs/ RBC Capital Markets/ Credit Suisse/ SMBC Nikko | 8.00 | $24.00 | $26.00 | $200.00 | n.a. |
| HubSpot (HUBS) | Morgan Stanley/ J.P. Morgan/ UBS Securitie | 5.00 | $22.00 | $24.00 | $115.00 | 3-Stars |
| Metaldyne Performance Group (MPG) | BofA Merrill Lynch/ Goldman Sachs/ Deutsche Bank SecuritieS/ Barclays/ Credit Suisse/ RBC Capital Markets | $150.00 | n.a. | |||
| Proteon Therapeutics (PRTO) | Stifel/ JMP Securities | 4.70 | $12.00 | $14.00 | $61.10 | n.a. |
| Virgin America (VA) | Barclays/ Deutsche Bank Securities | $115.00 | n.a. | |||
| Virobay (VBAY) | Piper Jaffray/ JMP Securities | 3.85 | $12.00 | $14.00 | $50.00 | 2-Stars |
| Xenon Pharmaceuticals (XENE) | Jefferies/ Wells Fargo Securities | 4.00 | $10.00 | $12.00 | $44.00 | 2-Stars |
| Zayo Group Holdings (ZAYO) | Morgan Stanley/ Barclays/ Goldman Sachs | 28.90 | $21.00 | $24.00 | $650.25 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Oct. 6, 2014 | Manager(s) | Offered | Raised | Price | 10/10/14 | Change |
| Diplomat Pharmacy (DPLO) | Credit Suisse/ Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities/ William Blair/ Leerink Partners | 13.33 | $173.33 | $13.00 | $16.02 | 23.23% |
| HubSpot (HUBS) | Morgan Stanley/ J.P. Morgan/ UBS Securitie | 5.00 | $125.00 | $25.00 | $29.05 | 16.20% |
| Veritex Holdings (VBTX) | Sandler ONeill + Partners/ Stephens | 2.70 | $35.10 | $13.00 | $14.89 | 14.54% |
| Dave & Buster’s Entertainment (PLAY) | Jefferies/ Piper Jaffray | 5.88 | $94.12 | $16.00 | $17.28 | 8.00% |
| OM Asset Management Ltd (OMAM) | BofA Merrill Lynch/ Morgan Stanley/ Citigroup/ Credit Suisse | 22.00 | $308.00 | $14.00 | $13.87 | -0.93% |
| USD Partners LP (USDP ) | Citigroup/ Barclays/ Credit Suisse/ BofA Merrill Lynch | 9.12 | $155.04 | $17.00 | $16.70 | -1.76% |
| Eagle Point Credit (ECC) | Deutsche Bank Securities/ Keefe, Bruyette & Woods (A Stifel Company)/ Wunderlich Securities/ JMP Securities/ National Securities/ MUFG/ Sterne Agee/ Compass Point | 5.16 | $103.11 | $20.00 | $19.15 | -4.25% |
| Great Basin Scientific (GBSN)(u) | Dawson James Securities, Inc. | 1.15 | $8.05 | $7.00 | $5.93 | -15.29% |
| MOL Global (MOLG) | Citigroup/ Credit Suisse/ Deutsche Bank Securities/ UBS Investment Bank (In alphabetical order) | 13.50 | $168.75 | $12.50 | $8.21 | -34.32% |
| u (unit offering) | ||||||
